EIM
CORV

Essex Investment Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Essex Investment Management’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-349,148
Closed -$698K – 524
2019
Q3 		$698K Sell
349,148
-212,054
-38% -$430K 0.1% 257
2019
Q2 		$1.21M Sell
561,202
-15,931
-3% -$40.7K 0.17% 193
2019
Q1 		$1.82M Buy
577,133
+443,249
+331% +$1.43M 0.27% 117
2018
Q4 		$333K Buy
+133,884
New +$446K 0.05% 278

Other funds holding CORV

TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Essex Investment Management's CORV Position: Q4 2019 in Review

Essex Investment Management sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2019, closing a stake of 349,148 shares — an estimated $698K sold.

Essex Investment Management first reported a position in CORV in Q4 2018 and held it in 4 quarters. The position peaked at $1.82M in Q1 2019. 31 funds tracked by Wall St. Rank hold CORV as of Q4 2019.

  • Essex Investment Management reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2019 after selling out during the quarter.
  • Essex Investment Management sold 349,148 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2019, an estimated $698K.
  • Essex Investment Management first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q4 2018 and held it in 4 quarters.
  • Essex Investment Management's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $1.82M in Q1 2019.
  • 31 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2019.

Based on Essex Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.